Analyzers, Point-of-Care, Whole Blood, Glucose/Lipid Profile

Definition : Point-of-care whole blood analyzers designed to measure the concentration of glucose, cholesterol, and lipids usually in a capillary blood sample (e.g., from a fingerstick). These analyzers may use one or more technologies such as reflectance photometry (i.e., by measuring the amount of light that is reflected from reagent-impregnated test pads or reagent strips that have reacted with the blood sample) and/or electrochemical methods. Glucose/lipid profile analyzers are capable of determining the concentration of glucose, high-density lipoprotein (HDL) and total cholesterol, and triglycerides. Some other related values (e.g., low-density lipoprotein [LDL] cholesterol) may be obtained using the analyzer software. The results are shown in the analyzer display; some analyzers include a printer for immediate printing of the results. Point-of-care glucose and lipid profile analyzers are used at the bedside, in operating rooms, and emergency departments; some are also intended for home use by patients with diabetes and/or heart diseases.

UMDC code : 34354

U.S.companies only
Suppress Subsidiary Companies

1-3 of 3 Match(es).

Alere Inc

Company Type: Parent

Alere Inc., a global healthcare company, announced a new partnership with Population Services International as part of the "Make (+) Positive More Positive Campaign.

Jant Pharmacal Corp

Company Type: Parent

PTS Diagnostics

Company Type: Parent

1-3 of 3 Match(es).


Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs
Medical Product Guide Cancer Therapy Advisor Product Zone